The FDA issued a warning regarding the potential risk of a rare but serious liver injury associated with the drug Veozah, a medication approved in May 2023 to treat moderate to severe hot flashes.
The closure of hundreds of pharmacies by major chains such as Walgreens and Rite Aid could signal a growing crisis in the industry, the executive director of the Ohio Pharmacists Association has said.
Sen. Peter Welch (D-Vt.) has introduced a bill that would ban pharmaceutical companies from restricting access to 340B drug pricing program discounts, according to a Sept. 11 press release shared with Becker's.
In a phase 3 clinical trial, liraglutide was shown to reduce the body mass index in children ages 6 to 11 with obesity, according to a study published Sept. 10 in The New England Journal of Medicine.
Tralia, the region with the highest rate of skin cancer globally. In recent years, sunscreen hasn’t just become about avoiding skin cancer, but in keeping us young and preventing wrinkles. It has transformed into a 2-in-1 way to moisturize and…
AstraZeneca's lung cancer drug datopotamab deruxtecan, also called Dato-DXd, failed to show a significant benefit to overall survival when compared to standard chemotherapy drug docetaxel, according to trial results published Sept. 9 in the Journal of Clinical Oncology.
In a phase 1/2 trial, researchers tested ATSN-101, a gene therapy for Leber congenital amaurosis 1, a rare genetic disorder that typically causes blindness in early childhood.
A recent American Medical Association found that 72% of insured individuals are covered by companies owning or closely linked to a pharmacy benefit manager. As a result, the organization is advocating for stronger regulatory oversight.
